EBS
Emergent BioSolutions Inc
Price:  
8.75 
USD
Volume:  
1,270,983.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EBS WACC - Weighted Average Cost of Capital

The WACC of Emergent BioSolutions Inc (EBS) is 6.1%.

The Cost of Equity of Emergent BioSolutions Inc (EBS) is 9.55%.
The Cost of Debt of Emergent BioSolutions Inc (EBS) is 5.50%.

Range Selected
Cost of equity 8.50% - 10.60% 9.55%
Tax rate 16.60% - 26.10% 21.35%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.2% - 7.1% 6.1%
WACC

EBS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1 1.03
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.50% 10.60%
Tax rate 16.60% 26.10%
Debt/Equity ratio 1.82 1.82
Cost of debt 4.00% 7.00%
After-tax WACC 5.2% 7.1%
Selected WACC 6.1%